Dr. Andreas Goutopoulos founded Actithera with the vision of bringing medicinal chemistry-driven innovation to radioligand therapy. He has over 25 years of experience in drug discovery, including leadership roles at EMD Serono, where he directed the chemistry organization, and at M Ventures, where he served as Entrepreneur-in-Residence supporting company creation and scientific diligence. Andreas has led the discovery of more than a dozen development candidates across therapeutic areas. His scientific leadership and commitment to precision molecular design continue to shape Actithera’s approach to building transformative oncology therapeutics.